Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Registry Study of Children and Adults Patients With Relapsed, Refractory, or Progressive Sonic Hedgehog Medulloblastoma Harboring U1 Mutation

NCT07242963 is registered in ClinicalTrials.gov with Mohammad H. Abu Arja as lead sponsor.

NCT NCT07242963
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07242963 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Registry Study of Children and Adults Patients With Relapsed, Refractory, or Progressive Sonic Hedgehog Medulloblastoma Harboring U1 Mutation
Lead sponsor
Mohammad H. Abu Arja
Phase
Observational
Overall status
Recruiting
Start date
September 30, 2025
Completion date
December 30, 2035
Enrollment
300 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

medulloblastoma recurrent, medulloblastoma, childhood, recurrent, medulloblastoma, shh-activated and tp53 mutant, medulloblastoma, shh-activated and tp53 wildtype